Published in Cancer Weekly, May 27th, 2003
"In this study, inducible nitric oxide synthase (iNOS) expression in a series of 158 human primary brain tumors was analyzed.
"To gain some insight into the biological significance of iNOS expression in tumor cells, comparative immunohistochemical analyses were employed to characterize the expression of iNOS, superoxide dismutase (SOD) proteins (SOD1 and SOD2), Ki-67 antigen (MIB-1) and p53 protein in these cells," investigators in Japan report.
"Sixteen (39.0%) of the 41 glioblastoma multiforme (GBM) specimens showed iNOS...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.